| 11945826 |
Hydroxypyridoxazepines as NRF2 activators |
Mark ELBAN, Michal Pawel GLOGOWSKI, Michael Clinton KOETTING, Brian Griffin Lawhorn, Jaclyn R. Patterson |
2024-04-02 |
|
| 11260049 |
TRPV4 antagonists |
Edward J. Brnardic, Carl Brooks, Brian Griffin Lawhorn, Peng Li, John Jeffrey McAtee +4 more |
2022-03-01 |
|
| 11229623 |
TRPV4 antagonists |
Edward J. Brnardic, Carl Brooks, Brian Griffin Lawhorn, Guosen Ye, Linda S. Barton +9 more |
2022-01-25 |
|
| 11028099 |
NRF2 activators |
Carl Brooks |
2021-06-08 |
|
| 10588891 |
TRPV4 antagonists |
Edward J. Brnardic, Carl Brooks, Brian Griffin Lawhorn, Guosen Ye, Linda S. Barton +9 more |
2020-03-17 |
|
| 10590077 |
TRPV4 antagonists |
Edward J. Brnardic, Carl Brooks, Brian W. Budzik, Brian Griffin Lawhorn, John Jeffrey McAtee +2 more |
2020-03-17 |
|
| 9434711 |
Sulfonamides as TRPM8 modulators |
Shawn Branum, Raymond W. Colburn, Scott L. Dax, Christopher Flores, Michele C. Jetter +11 more |
2016-09-06 |
$91,731,000 |
| 9233947 |
Sulfamides as TRPM8 modulators |
— |
2016-01-12 |
$76,770,000 |
| 9090639 |
Cold menthol receptor-1 antagonists |
Raymond W. Colburn, Scott L. Dax, Christopher Flores, Ning Qin, Laura W. Andraka +2 more |
2015-07-28 |
$45,878,000 |
| 9067935 |
Imidazo[1,2-α]pyridine sulfonamides as TRPM8 modulators |
Mark J. Macielag, Mingde Xia, James J. McNally |
2015-06-30 |
$80,032,000 |
| 8809327 |
Sulfonamides as TRPM8 modulators |
Shawn Branum, Raymond W. Colburn, Scott L. Dax, Christopher Flores, Michele C. Jetter +11 more |
2014-08-19 |
$49,487,000 |
| 8748478 |
Sulfamides as TRPM8 modulators |
— |
2014-06-10 |
$38,524,000 |
| 8629281 |
Cold menthol receptor-1 antagonists |
Raymond W. Colburn, Scott L. Dax, Christopher Flores, Ning Qin, Laura Reany +2 more |
2014-01-14 |
$61,222,000 |
| 8618150 |
Imidazo[1,2-α]pyridine sulfonamides as TRPM8 modulators |
Mark J. Macielag, Mingde Xia, James J. McNally |
2013-12-31 |
$42,973,000 |
| 8558011 |
Cold menthol receptor-1 antagonists |
Raymond W. Colburn, Scott L. Dax, Christopher Flores |
2013-10-15 |
$110,462,000 |
| 8436041 |
Sulfamides as TRPM8 modulators |
— |
2013-05-07 |
$59,807,000 |
| 8324217 |
Cold menthol receptor antagonists |
Raymond W. Colburn, Scott L. Dax, Christopher Flores, Donald Ludovici, Mingde Xia +3 more |
2012-12-04 |
$39,780,000 |
| 8216547 |
Radiolabelled TRP M8 receptor ligands |
Paul Acton, Dennis J. Hlasta, James J. McNally |
2012-07-10 |
$57,830,000 |
| 8153682 |
Sulfonamides as TRPM8 modulators |
Shawn Branum, Raymond W. Colburn, Scott L. Dax, Christopher Flores, Michele C. Jetter +11 more |
2012-04-10 |
$74,571,000 |
| 8143259 |
Cold menthol receptor antagonists |
Raymond W. Colburn, Scott L. Dax, Christopher Flores, Donald Ludovici, Mingde Xia +3 more |
2012-03-27 |
$67,488,000 |
| 7897781 |
Cold menthol receptor-1 antagonists |
Raymond W. Colburn, Scott L. Dax, Christopher Flores, Ning Qin, Laura Reany +2 more |
2011-03-01 |
$34,623,000 |
| 7763605 |
[1,4]benzodiazepines as vasopressin V2 receptor antagonists |
Bruce E. Maryanoff |
2010-07-27 |
$69,247,000 |
| 7351857 |
Methods of using substituted tetralins and indanes |
Xiaoli Chen, Keith Demarest, Jung Lee, Philip Rybczynski |
2008-04-01 |
$95,713,000 |
| 7317005 |
Tricyclic benzodiazepines as vasopressin receptor antagonists |
William J. Hoekstra, Alexey Borisovich Dyatkin, Bruce E. Maryanoff |
2008-01-08 |
$17,632,000 |
| 6765004 |
Indoloazepines as vasopressin receptor antagonists |
William J. Hoekstra, Michael N. Greco, Leonard R. Hecker, Bruce E. Maryanoff |
2004-07-20 |
|
